SCHEMBL6407023

SCHEMBL6407023

COc1cc2c(cc1Cl)C1(OC(=O)c3ccccc31)c1cc(Cl)c(OC)cc1O2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
TDP1 Q9NUW8 4/20 0.53
FTO Q9C0B1 3/20 0.53
HTT P42858 2/20 0.53
PRMT1 Q99873 2/20 0.53
RECQL P46063 2/20 0.53
BLM P54132 2/20 0.53
ACE2 Q9BYF1 2/20 0.53
CYP2C19 P33261 2/20 0.53
HPGD P15428 1/20 0.53
SMAD3 P84022 1/20 0.53
CYP3A4 P08684 3/20 0.53
LMNA P02545 6/20 0.52
USP2 O75604 2/20 0.52
ALDH1A1 P00352 2/20 0.52
NPSR1 Q6W5P4 3/20 0.44
POLB P06746 3/20 0.44
GPR55 Q9Y2T6 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10205338 0.86 MAPT (0.52) MAPTMEN1KMT2ATDP1FTO
SCHEMBL10265071 0.86 PRMT1 (0.56) MAPTMEN1KMT2ATDP1FTO
SCHEMBL1024927 0.85 MAPT (0.66) MAPTMEN1KMT2ATDP1FTO
SCHEMBL29349570 0.85 MAPT (0.66) MAPTMEN1KMT2ATDP1FTO
SCHEMBL13388766 0.85 MAPT (0.62) MAPTMEN1KMT2ATDP1FTO
SCHEMBL16181494 0.85 MAPT (0.53) MAPTMEN1KMT2ATDP1FTO
SCHEMBL13953177 0.85 MAPT (0.53) MAPTMEN1KMT2ATDP1FTO
SCHEMBL621683 0.84 CYP3A4 (0.51) MAPTMEN1KMT2ATDP1FTO
SCHEMBL14005748 0.83 MAPT (0.54) MAPTMEN1KMT2ATDP1FTO
SCHEMBL620637 0.82 CYP3A4 (0.51) MAPTMEN1KMT2ATDP1FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537853-A1 Use of a composition comprising a compound comprising a lacton ring and/or a corresponding coloring agent with an open ring for dyeing keratinuous fibers L'OREAL (FR) 2005-06-08 EP claimed
US-9745487-B2 Yellow thermochromic dyes, inks composition and level indicators CHROMATIC TECHNOLOGIES, INC. (US) 2017-08-29 US disclosed
US-9745487-B2 Yellow thermochromic dyes, inks composition and level indicators CHROMATIC TECHNOLOGIES, INC. (US) 2017-08-29 US disclosed
EP-3017010-B1 YELLOW THERMOCHROMIC DYES, INKS COMPOSITION AND LEVEL INDICATORS CHROMATIC TECH INC (US) 2017-05-17 EP disclosed
US-20170073359-A1 Optically-Detectable Enzyme Substrates and Their Method of Use MOLECULAR PROBES, INC. 2017-03-16 US disclosed
US-20160333210-A1 Yellow Thermochromic Dyes, Inks Composition And Level Indicators CHROMATIC TECHNOLOGIES, INC. (US) 2016-11-17 US disclosed
US-20160333210-A1 Yellow Thermochromic Dyes, Inks Composition And Level Indicators CHROMATIC TECHNOLOGIES, INC. (US) 2016-11-17 US disclosed
US-9399716-B2 Yellow thermochromic dyes, inks composition and level indicators CHROMATIC TECHNOLOGIES INC. (US) 2016-07-26 US disclosed
US-9399716-B2 Yellow thermochromic dyes, inks composition and level indicators CHROMATIC TECHNOLOGIES INC. (US) 2016-07-26 US disclosed
US-20160139135-A1 Optically-Detectable Enzyme Substrates and Their Method of Use LIFE TECHNOLOGIES CORP (US) 2016-05-19 US disclosed
WO-2015003046-A1 YELLOW THERMOCHROMIC DYES, INKS COMPOSITION AND LEVEL INDICATORS CHROMATIC TECHNOLOGIES INC. (US) 2015-01-08 WO disclosed
US-8865891-B2 Optically-detectable enzyme substrates and their method of use Life Technologies Corporation (US) 2014-10-21 US disclosed
EP-1537853-A1 Use of a composition comprising a compound comprising a lacton ring and/or a corresponding coloring agent with an open ring for dyeing keratinuous fibers L'OREAL (FR) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160139135-A1 Optically-Detectable Enzyme Substrates and Their Method of Use MGAM, LCT, GAA MAPT 2586/4885MEN1 3638/4885KMT2A 3746/4885
US-20170073359-A1 Optically-Detectable Enzyme Substrates and Their Method of Use MGAM, LCT, GAA MAPT 2586/4885MEN1 3638/4885KMT2A 3746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.